ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $237,000 | +33.1% | 1,372 | -2.5% | 0.01% | +25.0% |
| Q2 2021 | $178,000 | -7.3% | 1,407 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $192,000 | +23.1% | 1,413 | +15.6% | 0.00% | -33.3% |
| Q4 2020 | $156,000 | +32.2% | 1,222 | +15.0% | 0.01% | -14.3% |
| Q3 2020 | $118,000 | – | 1,063 | – | 0.01% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 6 | -71.4% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 21 | +40.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 15 | -53.1% | 0.00% | – |
| Q4 2015 | $2,000 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |